OOIR: Observatory of International Research

Papers

(The TQCC of Menopause-The Journal of the North American Menopause Society is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Psychometric properties and validity of the Menopause Rating Scale in postmenopausal Portuguese women	394
The effect of probiotic administration on the severity of menopausal symptoms and mental health of postmenopausal women: a triple-blind randomized controlled trial in the West of Iran	105
Migraine and sleep quality: does the association change in midlife women?	44
Reflecting on the enduring effects of childhood maltreatment	22
Validation of the Menopause Transition Scale (MTS)	20
Risk factors for delayed intrauterine device removal among menopausal women in rural China	18
A call for health equity when addressing menopausal symptoms	16
Urban-rural differences in epidemiology and risk factors of menopause syndrome in middle-aged Chinese women	16
Health screening of middle-aged women: what factors impact longevity?	15
#Menopause: the menopause ontology project	15
Dietary patterns and prevalence of multimorbidity in women in southern Brazil	14
Treating where it hurts: tailoring the genitourinary syndrome of menopause treatments	13
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis	12
Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages	12
Lessons Learned in Clinical Research Recruitment of Midlife Latinas During COVID-19	12
Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors	11
The prevalence of osteoporosis in postmenopausal women in urban Tianjin, China and its related factors	10
Low-serum anti-Müllerian hormone in middle-aged women associates with obesity markers	10
Perimenopause meets life: observations from the Women Living Better Survey	10
Association between vitamin D and calcium intakes, breast microcalcifications, breast tissue age-related lobular involution and breast density	10
The association of vasomotor symptoms during the menopausal transition and cognition in later life	10
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study	9
Risk factors for future osteoporosis in perimenopausal Japanese women	9
The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study	9
Menopause hormone therapy and urinary symptoms: a systematic review	9

Examining long-term health impacts of multiparity	8
Impact of the CBT-Meno protocol on menopause-specific beliefs, dysfunctional attitudes, and coping behaviors	8
Pharmacological interactions and menopausal hormone therapy: a review	8
Health care concerns in women at midlife: differences by race, ethnicity, and neighborhood socioeconomic status	8
Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis	8
Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN)	8
Association of parity with body mass index and cardiometabolic risk in high-parous women	8
Exercise training and vascular function in postmenopausal individuals: a systematic review and meta-analysis	8
Network analysis of eating disorder symptoms in women in perimenopause and early postmenopause	7
Letters to the editor	7
Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden	7
Efficacy and safety of lemborexant in midlife women with insomnia disorder	7
Screening for factors at midlife associated with reduced longevity in women	7
Indian physicians' attitudes and practice regarding menopause and its management: a focus group discussion	7
The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context	7
Psychometric evaluation of the German Day-to-Day Impact of Vaginal Aging questionnaire using data from two intervention studies	7
Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging	6
Impact of vitamin D supplementation on modulating heat-shock proteins in postmenopausal women: a randomized, double-blind, placebo-controlled study	6
Nonhormone treatments for vasomotor symptoms	6
Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?	6
Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial	6
Climacteric status is associated with sexual dysfunction at the age of 46 years: a population-based study	6
Postmenopausal giant ovarian tumor: a rare case report and literature review	6
Does the addition of serum antimüllerian hormone concentrations to the Framingham Risk Score and Pooled Cohort Equations improve the prediction of cardiovascular disease?	6
Menopause: The Journal of The North American Menopause Society Volume 29, 2022	6
Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis	5
Genitourinary syndrome of menopause—I know it when I see it—or do I?	5
Should vitamin D supplements be prescribed routinely for midlife women?	5
Uterine arcuate artery calcification as a potential marker of cardiovascular risk—a preliminary study	5
Hysterectomy with or without ovarian conservation: similar associations with vascular health?	5
Psychometric properties of a Persian version of the Vulvovaginal Symptoms Questionnaire for measuring vulvovaginal symptoms in postmenopausal women	5
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)	5
Interactions between nutrient intake and comorbidities for quality of life in premenopausal and postmenopausal women	5
2022 Annual Meeting of The North American Menopause Society October 12 – 15, 2022, Atlanta, GA	5
Menopause for justice-involved women: consequences and care in prison systems	5
Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update	5
Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study	5
Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers	5
Prasterone in the treatment of mild to moderate urge incontinence: an observational study	5